Cardiovascular medication use and risk for colorectal cancer.

Publication Type:

Journal Article


Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Volume 17, Issue 11, p.3076-80 (2008)


2008, Aged, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Calcium Channel Blockers, Cardiovascular Diseases, Case-Control Studies, Colorectal Neoplasms, Female, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Incidence, Logistic Models, Male, Public Health Sciences Division, RISK, SEER Program, Washington


To evaluate the association between lipid-lowering agents, antihypertensive medications, and colorectal cancer risk. We hypothesized a reduction in colorectal cancer risk with 3-hydroxy-3-methylglutaryl coA reductase inhibitors (statins) and angiotensin-converting enzyme inhibitors.